◆ Market Terminal AILook up a stock

Scribe Therapeutics Inc. (SCTX)

Healthcare · Biotechnology · Small-cap · updated October 16, 2026

NOT A BUY TODAY
What this means. Its share price has been weak.
Value-
Quality-
Price trend17
Overall43
2080 of 2764rank among the US stocks we score (our core model buys the top 15)
25%of US stocks we score rank below it

Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.

Insider trades, last 90 days

6 insiders bought $71.3M on the open market.

Aghazadeh Behzad; Avoro Capital Advisors LLC; Avoro Ventures LLCDirector; Director · 10% ownerBoughtJul 287,905 shat $18.25 · $144K
Orbimed Advisors Llc; OrbiMed Capital GP VIII LLCDirectorBoughtJul 271,000,000 shat $15.00 · $15.0M
Gordon Carl LDirectorBoughtJul 271,000,000 shat $15.00 · $15.0M

From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.

Higher-scoring in the same industry

Interactive lookupGet the Ledger every Monday

Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy